Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
30.08
-1.09 (-3.50%)
Oct 31, 2025, 4:00 PM EDT - Market closed
Caris Life Sciences Revenue
Caris Life Sciences had revenue of $181.40M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $533.85M. In the year 2024, Caris Life Sciences had annual revenue of $412.26M with 34.67% growth.
Revenue (ttm)
$533.85M
Revenue Growth
+34.67%
P/S Ratio
2.42
Revenue / Employee
$301,779
Employees
1,769
Market Cap
8.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | 47.64M | 18.43% |
| Dec 31, 2022 | 258.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAI News
- 5 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 5 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 5 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 5 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC